Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

TIM-3 regulates innate immune cells to induce fetomaternal tolerance.

Chabtini L, Mfarrej B, Mounayar M, Zhu B, Batal I, Dakle PJ, Smith BD, Boenisch O, Najafian N, Akiba H, Yagita H, Guleria I.

J Immunol. 2013 Jan 1;190(1):88-96. doi: 10.4049/jimmunol.1202176. Epub 2012 Nov 23.

2.

Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells.

Tripathi S, Chabtini L, Dakle PJ, Smith B, Akiba H, Yagita H, Guleria I.

PLoS One. 2015 Apr 21;10(4):e0123439. doi: 10.1371/journal.pone.0123439. eCollection 2015.

3.

Up-regulation of Tim-3 expression contributes to development of burn-induced T cell immune suppression in mice.

Tang Z, Yu Y, Qiu W, Zhang J, Yang X.

J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):642-51. doi: 10.1007/s11596-011-0575-0. Epub 2011 Oct 25.

PMID:
22038354
4.

Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.

Dardalhon V, Anderson AC, Karman J, Apetoh L, Chandwaskar R, Lee DH, Cornejo M, Nishi N, Yamauchi A, Quintana FJ, Sobel RA, Hirashima M, Kuchroo VK.

J Immunol. 2010 Aug 1;185(3):1383-92. doi: 10.4049/jimmunol.0903275. Epub 2010 Jun 23.

5.

Sphingolipid pathway regulates innate immune responses at the fetomaternal interface during pregnancy.

Mizugishi K, Inoue T, Hatayama H, Bielawski J, Pierce JS, Sato Y, Takaori-Kondo A, Konishi I, Yamashita K.

J Biol Chem. 2015 Jan 23;290(4):2053-68. doi: 10.1074/jbc.M114.628867. Epub 2014 Dec 11.

6.

TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.

Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH.

Immunol Rev. 2010 May;235(1):172-89. doi: 10.1111/j.0105-2896.2010.00903.x. Review.

7.

Feto-maternal immune regulation by TIM-3/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy.

Meggyes M, Lajko A, Palkovics T, Totsimon A, Illes Z, Szereday L, Miko E.

Placenta. 2015 Oct;36(10):1153-60. doi: 10.1016/j.placenta.2015.07.124. Epub 2015 Jul 18.

PMID:
26278059
8.

B7h (ICOS-L) maintains tolerance at the fetomaternal interface.

Riella LV, Dada S, Chabtini L, Smith B, Huang L, Dakle P, Mfarrej B, D'Addio F, Adams LT, Kochupurakkal N, Vergani A, Fiorina P, Mellor AL, Sharpe AH, Yagita H, Guleria I.

Am J Pathol. 2013 Jun;182(6):2204-13. doi: 10.1016/j.ajpath.2013.02.014. Epub 2013 Apr 8.

9.

Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation.

Nakayama M, Akiba H, Takeda K, Kojima Y, Hashiguchi M, Azuma M, Yagita H, Okumura K.

Blood. 2009 Apr 16;113(16):3821-30. doi: 10.1182/blood-2008-10-185884. Epub 2009 Feb 17.

10.

T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.

Uchida Y, Ke B, Freitas MC, Yagita H, Akiba H, Busuttil RW, Najafian N, Kupiec-Weglinski JW.

Gastroenterology. 2010 Dec;139(6):2195-206. doi: 10.1053/j.gastro.2010.07.003. Epub 2010 Jul 13.

11.

Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes.

Zhang Y, Ma CJ, Wang JM, Ji XJ, Wu XY, Moorman JP, Yao ZQ.

J Leukoc Biol. 2012 Feb;91(2):189-96. doi: 10.1189/jlb.1010591. Epub 2011 Aug 15.

12.

Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.

Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA.

Science. 2007 Nov 16;318(5853):1141-3.

13.

Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity.

Zhao J, Lei Z, Liu Y, Li B, Zhang L, Fang H, Song C, Wang X, Zhang GM, Feng ZH, Huang B.

J Immunol. 2009 May 15;182(10):6618-24. doi: 10.4049/jimmunol.0803876.

14.

Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

Nagahara K, Arikawa T, Oomizu S, Kontani K, Nobumoto A, Tateno H, Watanabe K, Niki T, Katoh S, Miyake M, Nagahata S, Hirabayashi J, Kuchroo VK, Yamauchi A, Hirashima M.

J Immunol. 2008 Dec 1;181(11):7660-9.

15.

Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease.

Oikawa T, Kamimura Y, Akiba H, Yagita H, Okumura K, Takahashi H, Zeniya M, Tajiri H, Azuma M.

J Immunol. 2006 Oct 1;177(7):4281-7.

16.

The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.

Ju Y, Shang X, Liu Z, Zhang J, Li Y, Shen Y, Liu Y, Liu C, Liu B, Xu L, Wang Y, Zhang B, Zou J.

Mol Immunol. 2014 Mar;58(1):85-91. doi: 10.1016/j.molimm.2013.11.001. Epub 2013 Dec 10.

PMID:
24333756
17.

Emerging Tim-3 functions in antimicrobial and tumor immunity.

Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK.

Trends Immunol. 2011 Aug;32(8):345-9. doi: 10.1016/j.it.2011.05.003. Epub 2011 Jun 21. Review.

18.

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Liu Y, Ji H, Zhang Y, Shen X, Gao F, He X, Li GA, Busuttil RW, Kuchroo VK, Kupiec-Weglinski JW.

J Hepatol. 2015 Mar;62(3):563-72. doi: 10.1016/j.jhep.2014.10.034. Epub 2014 Oct 31.

20.

The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse.

Uchida Y, Ke B, Freitas MC, Ji H, Zhao D, Benjamin ER, Najafian N, Yagita H, Akiba H, Busuttil RW, Kupiec-Weglinski JW.

Hepatology. 2010 Apr;51(4):1363-72. doi: 10.1002/hep.23442.

Supplemental Content

Support Center